The Mid-term Elections Will Not Resolve the Dysfunction at HHS

By STEVEN ZECOLA Introduction. The scientists at the Department of Health and Human Services (“HHS”) are breathing a sigh of relief given that the Democrats will be taking control of the House and Senate. For the past two years, there has been a tension within HHS between the scientific community and President Trump’s executive appointments….

Read More

Brain-Focused Startup Oyster Gets $60M to Beat the Size Problem for Small Molecule Degraders

Oyster Therapeutics’ lead program penetrates the brain to degrade pathological tau associated with Alzheimer’s disease. Eli Lilly, maker of the amyloid-targeting Alzheimer’s drug Kisunla, participated in the startup’s new financing. The post Brain-Focused Startup Oyster Gets $60M to Beat the Size Problem for Small Molecule Degraders appeared first on MedCity News.

Read More